Found: 25
Select item for more details and to access through your institution.
Low levels of ADAMTS‐13 with high anti‐ADAMTS‐13 antibodies during remission of immune‐mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi‐institutional study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. 953, doi. 10.1002/ajh.25845
- By:
- Publication type:
- Article
Acquired cyclic neutropenia associated with cocaine‐induced anti‐neutrophil cytoplasmic antibodies binding to human neutrophil elastase.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. E227, doi. 10.1002/ajh.25197
- By:
- Publication type:
- Article
Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E162, doi. 10.1002/ajh.25106
- By:
- Publication type:
- Article
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 58, doi. 10.1002/ajh.24935
- By:
- Publication type:
- Article
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 617, doi. 10.1002/ajh.24362
- By:
- Publication type:
- Article
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 553, doi. 10.3390/cells11030553
- By:
- Publication type:
- Article
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2764, doi. 10.3390/cells10102764
- By:
- Publication type:
- Article
Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 436, doi. 10.1111/ejh.13680
- By:
- Publication type:
- Article
Impact of Arterial Thrombotic Events on the Outcome of Chronic Myeloid Leukemia Patients Treated with Nilotinib First-Line: A GIMEMA CML WP Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S313, doi. 10.1016/j.clml.2017.07.114
- By:
- Publication type:
- Article
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 1, p. 43, doi. 10.1111/j.1365-2141.2004.04993.x
- By:
- Publication type:
- Article
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2041, doi. 10.1002/cam4.2087
- By:
- Publication type:
- Article
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 2687, doi. 10.2147/DDDT.S79576
- By:
- Publication type:
- Article
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 23, p. 5069, doi. 10.1002/cncr.33160
- By:
- Publication type:
- Article
The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 10, p. 1674, doi. 10.1002/cncr.31977
- By:
- Publication type:
- Article
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Accessory spleens recapitulate the immune microenvironment of the main spleen in immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 1, p. 147, doi. 10.1111/bjh.18749
- By:
- Publication type:
- Article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
Deferasirox in the management of iron‐overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON‐M study).
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. e123, doi. 10.1111/bjh.15964
- By:
- Publication type:
- Article
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 35, doi. 10.1111/bjh.15497
- By:
- Publication type:
- Article
Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1726, doi. 10.1002/cam4.3778
- By:
- Publication type:
- Article
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0218444
- By:
- Publication type:
- Article
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 16, p. 5267, doi. 10.3390/jcm12165267
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article